6 terminated. 6 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Terminated 6 |
| Phase 1 | 1 | Terminated 1 |
Follow Aplastic Anemia: new trials by email Literature Review of Aplastic Anemia trials Research Report on Aplastic Anemia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer Cyclophosphamide, Fludarabine Phosphate, Laboratory Biomarker Analysis - Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission | Phase 2 | Terminated | Roswell Park Cancer Institute | 31 | 2017-12-07 | 2025-07-04 |
| Pooled Unrelated Donor Umbilical Cord Blood Transplant For Hematologic Malignancy Needing Allogeneic Stem Cell Transplant Without Related HLA-Match Busulfan, Clofarabine, Fludarabine - Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia | Phase 2 | Terminated | Texas Oncology Cancer Center | 1 | 2011-11-01 | 2013-11-25 |
| Treatment of Menorrhagia in Women With Thrombocytopenia Using Platelets or Platelets and Hormones Lo-Ovral Oral Contraceptive Pills, Placebo - sugar pill - Aplastic Anemia, Menorrhagia | Phase 1 / Phase 2 | Terminated | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1 | 2007-11-01 | 2013-07-19 |
| A Phase II Study of Umbilical Cord Blood Transplantation Umbilical Cord Blood After Myeloablative Conditioning, Umbilical Cord Blood After Reduced-Intensity Conditioning - Leukemia, Lymphoma | Phase 2 | Terminated | Tufts Medical Center | 7 | 2005-07-01 | 2017-06-01 |
| Allogeneic Stem Cell Transplant for Patients With Severe Aplastic Anemia Cytoxan, Campath, Total Body Irradiation (TBI) - Aplastic Anemia | Phase 2 | Terminated | Baylor College of Medicine | 22 | 2002-02-01 | 2016-04-22 |
| A Study to Determine Whether Therapy With Daclizumab Will Benefit Patients With Bone Marrow Failure Daclizumab - Aplastic Anemia, Pure Red Cell Aplasia | Phase 2 | Terminated | National Heart, Lung, and Blood Institute (NHLBI) | 100 | 1999-11-01 | 2021-07-09 |
Anemia, Aplastic (6) · Multiple Myeloma (3) · Anemia, Diamond-Blackfan (2) · Leukemia (2) · Leukemia, Lymphocytic, Chronic, B-Cell (2) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (2) · Leukemia, Myeloid, Acute (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Myelodysplastic Syndromes (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Amenorrhea (1) · Anemia, Refractory, with Excess of Blasts (1) · Anemia, Sickle Cell (1) · Congenital amegakaryocytic thrombocytopenia (1)
Anemia (6) · Bone Marrow Diseases (6) · Bone Marrow Failure Disorders (6) · Hematologic Diseases (6) · Hemic and Lymphatic Diseases (6) · Immune System Diseases (4) · Immunoproliferative Disorders (4) · Lymphatic Diseases (4) · Lymphoproliferative Disorders (4) · Neoplasms (4) · Neoplasms by Histologic Type (4) · Blood Protein Disorders (3) · Cardiovascular Diseases (3) · Hemorrhagic Disorders (3) · Hemostatic Disorders (3)
Cyclophosphamide (3) · Busulfan (2) · Whole-Body Irradiation (2) · fludarabine phosphate (2) · Alemtuzumab (1) · Carmustine (1) · Clofarabine (1) · Cytarabine (1) · Daclizumab (1) · Etoposide (1) · Ficusin (1) · Melphalan (1) · Methotrexate (1) · Peripheral Blood Stem Cell Transplantation (1) · Radiation (1)
Baylor College of Medicine (1) · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · Roswell Park Cancer Institute (1) · Texas Oncology Cancer Center (1) · Tufts Medical Center (1)
United States (6)
Andreas Klein, MD (1) · Kathryn Leung, MD (1) · Neal Young, MD (1) · Pamela Stratton, MD (1) · Philip McCarthy, MD (1) · Seah Lim, MD (1)